SEC Form 4 · accession 0000891293-15-000048
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 6:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 29, 2015 | S | 5,600 | $1.38 | D | 1,446,250 | D | |
| Common Stock | Sep 29, 2015 | S | 7,300 | $1.39 | D | 1,438,950 | D | |
| Common Stock | Sep 29, 2015 | S | 15,083 | $1.40 | D | 1,423,867 | D | |
| Common Stock | Sep 29, 2015 | S | 9,263 | $1.405 | D | 1,414,604 | D | |
| Common Stock | Sep 29, 2015 | S | 28,254 | $1.41 | D | 1,386,350 | D | |
| Common Stock | Sep 29, 2015 | S | 250 | $1.415 | D | 1,386,100 | D | |
| Common Stock | Sep 29, 2015 | S | 6,094 | $1.42 | D | 1,380,006 | D | |
| Common Stock | Sep 29, 2015 | S | 3,156 | $1.425 | D | 1,376,850 | D | |
| Common Stock | Sep 30, 2015 | S | 5,115 | $1.45 | D | 1,371,735 | D | |
| Common Stock | Sep 30, 2015 | S | 751 | $1.4525 | D | 1,370,984 | D | |
| Common Stock | Sep 30, 2015 | S | 100 | $1.455 | D | 1,370,884 | D | |
| Common Stock | Sep 30, 2015 | S | 19,034 | $1.46 | D | 1,351,850 | D |
Table II — derivative securities
No Table II lines on this filing.